Video
Dr. Min Dong discusses ongoing research with onabotulinumtoxinA for patients with urologic disease
Author(s):
“Botox has been a wonderful drug for many, many years,” says Min Dong, MD.
In this video, Min Dong, MD, summarizes the ongoing and future research related to Botox therapies for urologic diseases. These ideas stem from the talk he gave at the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction 2022 Winter Meeting, titled, “New frontiers in therapeutic toxins for urologic disease.” Dong is an associate professor of urology at Harvard Medical School in Cambridge, Massachusetts.
Related Videos
Related Content
